The mouse mutant med J contains a splice site mutation in the neuronal sodium channel Scn8a that results in a very low level of expression. On a C57BL/6J genetic background, med J homozygotes exhibit progressive paralysis and juvenile lethality. The C3H genetic background has an ameliorating effect, producing viable adults with a novel dystonic phenotype. The dystonic mice exhibit movement-induced, sustained abnormal postures of the trunk and limbs. A dominant modifier locus responsible for the difference between strains was mapped to a 4.5 ± 1.3 cM interval on mouse chromosome 3. Our findings establish a role for ion channels in dystonia and demonstrate the impact of genetic background on its severity and progression. This new model suggests that SCN8A on chromosome 12q13 and SCNM1 on chromosome 1p21-1q21 may contribute to human inherited dystonia.
INTRODUCTION
Dystonia is a heterogeneous neurological disorder characterized by involuntary muscle contraction that produces twisting movements and sustained abnormal postures. The most common dystonias seen in clinical practice are idiopathic dystonia, with an estimated prevalence of 3/100 000, and focal dystonia, with an estimated prevalence of 30/100 000 (1). Many cases of dystonia are thought to be inherited. Mutations have been identified in two enzymes in the dopamine synthesis pathway (2, 3) and in the torsin A gene at the DYT1 locus on chromosome 9 (4, 5) , and five additional dystonia loci have been mapped. The penetrance of torsin A mutations is only 30-40%, suggesting that genetic background, environmental influences and other factors may be important in the etiology of the human disorder. No morphological abnormalities have been observed in brains of patients with idiopathic dystonia. The currently available treatments for this disabling condition are palliative and development of effective therapy has been hindered by the absence of animal models that resemble the human disease (6) .
Ion channel genes have been associated with inherited ataxia and epilepsy, but a role in dystonia has not previously been demonstrated. The voltage-gated sodium channels are responsible for the rapid depolarization phase of the action potential (7) (8) (9) . The sodium channel Scn8a is expressed in neurons throughout the brain and spinal cord but not in muscle (10) (11) (12) . Mutations in Scn8a are associated with neurological disease in the mouse (13) . Two null mutations, med and med tg , result in progressive paralysis and juvenile lethality due to a failure of evoked transmitter release at the neuromuscular junction (10, 14, 15) . One amino acid substitution in Scn8a causes ataxia (16) . The fourth mutant allele, med J , is a splice site mutation with a premature stop codon (17) . On a C57BL/6J background, the phenotype of med J homozygotes is nearly identical to the null mutants, except for a 1 week increase in survival time (17, 18) . Because of the phenotype and the premature stop codon, med J was previously classified as a null allele (17) .
It is not unusual for the severity of mouse mutant phenotypes to vary on different inbred backgrounds. This strain variation has been used to map modifier genes affecting spina bifida and neural tube defects (19, 20) , cystic fibrosis (21) and embryonic lethality of TGFβ1 deficiency (22) . Enhancer/suppressor screens have been widely used in non-mammalian genetics to identify loci affecting a functional pathway (23, 24) . Anecdotal evidence that the survival of med J mice is increased by several months in offspring of crosses with strain C3H (18, 25) provided an opportunity to investigate a potential modifier of sodium channel function. We have demonstrated that strain C57BL/6J carries a recessive susceptibility allele at a major modifier locus. We describe a novel phenotype of the med J mutation that has implications for the role of SCN8A in human dystonia and we provide evidence for the feasibility of cloning the modifier gene.
RESULTS

Dystonia in homozygous med J mice
Sixty percent of the homozygous med J F2 progeny of an intercross between strains C57BL/6J-med J and C3H survive to adulthood and display a novel dystonic phenotype. Movement in *To whom correspondence should be addressed. Tel: +1 734 763 5546; Fax: +1 734 763 9691; Email: meislerm@umich.edu these animals is accompanied by tremor and by severe twisting of the trunk (Fig. 1A) . Abnormal postures of the trunk and limbs are sustained for periods of 2-10 s in younger animals and up to 1 min in older animals (Fig. 1B) . The degree of flexion or extension at a given joint is variable and is often extreme. Dystonic posturing occurs frequently and is usually evident within a single traverse of the home cage. The dysfunction is persistent and coordinated gait is never observed. No abnormal movements are observed when the animals are at rest.
In addition to this generalized kinesiogenic dystonia, affected animals exhibit muscle weakness and have difficulty supporting their head and body (Fig. 1C) . The righting reflex is normal, but falling often induces axial twisting. Dystonic mice are docile; they attempt to escape when handled but do not bite. Fighting has not been observed even among unrelated males housed together. Some females have reproduced, but homozygous males do not breed. More than 80% of the dystonic mice survive beyond 1 year of age.
This phenotype is quite different from the progressive paralysis and juvenile lethality previously described for med J homozygotes on the C57BL/6J background (17) . In these mice, tremor and ataxia are first observed at 10-12 days of age and muscle atrophy is severe by 3 weeks. Among 130 C57BL/6J-med J /med J animals examined, 90% died between 3 and 4 weeks of age and none survived >6 weeks.
Brain and muscle histopathology of dystonic med J mice
No striking changes in morphology or neuronal cell number were observed in brain or spinal cord of the dystonic mice (Fig. 2) . No signs of abnormal gliosis were detected in dystonic brain by immunohistochemistry with an antiserum to glial fibrillary acidic protein and no evidence of neurodegeneration was revealed by silver staining (data not shown).
Although dystonic med J homozygotes do not exhibit extensive muscle wasting, histological examination of biceps brachii and gastrocnemius muscles revealed a greater variation in fiber diameter than in wild-type muscle ( Fig. 3A and C) . Mutant muscle also contains many fibers with central nuclei (Fig. 3A and B, arrows). These observations are consistent with partial functional denervation of the mutant muscle leading to secondary muscle fiber regeneration. Succinate dehydrogenase and myofibrillar ATPase staining did not demonstrate a preferential effect on type I or type II fibers (data not shown). The histological changes in skeletal muscle are consistent with the weakness that is apparent in Figure 1C .
True null mutants of Scn8a exhibit only the lethal paralytic phenotype
We examined the ability of the C3H genetic background to modify the lethal phenotype of two null mutants of Scn8a. The transgene-induced null allele Scn8a med-tg arose and is maintained in strain C57BL/6J (26) . We examined 27 transgenic homozygotes from the F2 generation of the cross (C57BL/6J-med tg /+ × C3HeB/FeJ). All of the homozygotes were affected with the paralytic phenotype and died within 4 weeks after birth. We also analyzed the original med allele, a null mutation caused by insertion of a L1 element (17) . This allele is routinely maintained in a C3H background. Among >100 affected med homozygotes examined, none survived beyond 1 month of age and none exhibited the dystonic phenotype. These observations reveal a fundamental difference between the true null mutations and med J .
A low level of correctly spliced Scn8a transcript is present in med J mice
Since the med J mutation alters a splice donor site without changing the coding sequence of Scn8a, we tested the possibility that inefficient splicing of the mutant site generates a low level of full-length transcripts that protect med J homozygotes from the inevitable lethality associated with the true null mutations. med J homozygotes with both the paralytic and the dystonic phenotypes were examined. Due to the combined effect of the 4 bp deletion in the splice donor site of exon 3 and the non-consensus AT-AC splice sites of intron 2, the major Scn8a transcript in med J brain is spliced from exon 1 to exon 4 and contains an in-frame stop codon within exon 4 (17; Fig. 4A and B). When RT-PCR is carried out with a forward primer from exon 1 and a reverse primer from exon 6, a 771 bp product is amplified from wild-type brain RNA and a 562 bp product lacking exons 2 and 3 is amplified from med J brain (Fig. 4C) . None of the correctly spliced 771 bp product could be detected in either dystonic or paralyzed mutants by ethidium bromide staining. This result is in agreement with previous experiments on paralyzed mutants (17) .
In order to specifically amplify any full-length transcript that might be present in the mutant, we carried out RT-PCR with primers from exons 2 and 4 ( Fig. 4B) . The predicted 243 bp product was obtained from both normal and mutant RNA (Fig. 4C ), indicating that some correctly spliced transcripts are present in med J homozygotes. Sequencing of gel purified fragments confirmed that the med J product was correctly spliced and included exons 2 and 3. In this assay, the lack of competition from the abundant mutant transcript, which does not hybridize with the exon 2 primer, permits amplification of the full-length transcript in spite of its low abundance in med J RNA.
Splicing efficiency does not differ between paralyzed and dystonic mice
To determine whether the proportion of correctly spliced transcript is different in mice with the paralyzed and dystonic phenotypes, we amplified both transcripts from each RNA sample using primers from exons 1 and 4. These primers amplify a 357 bp fragment from the full-length transcript and a 148 bp fragment from the incorrectly spliced transcript (Fig. 4B) . By ethidium bromide staining only the 148 bp product was visible in the homozygous med J samples (data not shown), as above with primers in exons 1 and 6. A more sensitive assay for the correctly spliced transcript was obtained by blotting the RT-PCR products onto nylon filters and hybridizing with a radiolabeled oligonucleotide that spans the exon 3-exon 4 junction and is specific for the full-length transcript (Fig. 4B, oligo A) . A low level of the full-length 357 bp product hybridizing with oligo A could be detected in the med J samples after a 48 h exposure (Fig. 4E) . The blot was stripped and rehybridized with oligo B specific for the exon 1-exon 4 junction in the mutant transcript (Fig. 4B) . The abundant, incorrectly spliced 148 bp product was detected after a 40 min exposure (Fig. 4E) . The ratio of the full-length 357 bp product to the incorrectly spliced 148 bp product did not appear to differ in samples from two paralyzed and two dystonic med J mice (Fig. 4E ) and this was confirmed by densitometry (data not shown). Comparison with diluted aliquots of RT-PCR products amplified from +/+ RNA indicated that the abundance of correctly spliced transcripts in med J homozygotes is ∼2% of the wild-type level (Fig. 4E) .
Segregation of a modifier locus in crosses between strain C57BL/6J and C3H
Among 854 F2 animals from an intercross between strains C57BL/6J-med J /+ and C3H, there were 212 animals with visible neurological disease (24.8%), consistent with the expectation of 25% homozygosity for the recessive mutation. Among the homozygotes, two clearly distinct phenotypes were apparent. Sixty percent of the affected animals (n = 127) exhibited the dystonic phenotype and survived to adulthood (Fig. 5A, solid  bars) . The remaining F2 med J homozygotes exhibit the paralyzed phenotype with juvenile lethality and died before 6 weeks of age (Fig. 5A, open bar) .
The genetic basis for the segregation of two different phenotypes was examined by analysis of genomic DNA from a subset of 19 paralyzed mice (pool 1) and 20 dystonic mice (pool 2). The two pools were analyzed for 62 microsatellite markers from 20 chromosomes. We observed a deficiency of the C57BL/6J allele of the marker D3Mit6 in the dystonic pool and deficiency of the C3H allele in the paralyzed pool (Fig. 5B) . This was confirmed by analysis of the individual samples. None of the other markers showed reproducible skewing. These data suggested that a modifier gene responsible for the phenotypic difference is present on chromosome 3.
Localization of the modifier locus Scnm1 on mouse chromosome 3
Genomic DNA samples from 111 mice with dystonia that had survived beyond 4 months of age were typed for microsatellite markers from the central region of chromosome 3 (Fig. 6A) . All of the dystonic mice were either homozygous or heterozygous for the C3H allele at marker D3Mit141. The data are consistent with segregation of a dominant modifier locus, designated sodium channel modifier 1 (Scnm1). The modifer locus was mapped to the 4.5 cM interval between D3Mit40 and D3Mit101 (Fig. 6B) .
Mode of inheritance of Scnm1
The penetrance of the dominant dystonic phenotype in Scnm1 H homozygotes and heterozygotes was estimated from the genotypes of the F2 animals. Among 55 F2 animals with juvenile lethality, 32 were BB, 16 were BH and 7 were HH at D6Mit141. Among 111 F2 mice with dystonia, 48 were HH and 63 were BH (Fig. 6A) . We extrapolated these genotype frequencies to the total F2 population of 85 juvenile lethal and 127 adult dystonic mice. The penetrance of the dystonic phenotype was calculated by dividing the number of dystonic mice by the total number of med J homozygotes with each Scnm1 genotype. The calculated penetrance for survival was 83% for HH homozygotes, 74% for BH The correctly spliced 243 bp product is amplified from homozygous paralytic and dystonic med J mice and age-matched C57BL/6J controls. (E) Proportions of full-length and incorrectly spliced transcript in med J homozyotes with the paralytic and dystonic phenotypes. RT-PCR was carried out using primers from exons 1 and 4. Products were transferred to a nylon filter and hybridized with oligo A and X-ray film was exposed for 48 h. The filter was washed and rehybridized with oligo B and film was exposed for 40 min. Two paralyzed F2 homozygotes and two dystonic F2 homozygotes were analyzed. Aliquots of diluted wild-type PCR product containing 1 or 2% of the total were included for comparison. heterozygotes and 0% for BB homozygotes. The genotype data are thus consistent with segregation of a single modifier locus with the C3H allele dominant to the C57BL/6J allele and with penetrance of ∼80% for the dominant allele. The similar penetrance of the HH and BH genotypes suggests that gene dosage effects for the modifier locus are minimal. Since all dystonic mice carry at least one Scnm1 H allele, this allele is necessary to prevent juvenile lethality. However, the early death of 20% of the mice carrying the Scnm1 H allele demonstrates that this allele is not always sufficient for survival, due to the incomplete penetrance.
Other strains of mice carry the dominant allele of Scnm1
To determine whether the susceptibility phenotype of C57BL/6J mice was unique to that strain, we carried out two additional intercrosses of C57BL/6J-med J /+ mice. In crosses with strains DBA/2J and A/J, both paralyzed and dystonic mice were observed in the F2 generation. The distribution of the two phenotypes was very similar to that in the C3H cross ( Fig. 7A  and B) . To determine whether the phenotypic difference segregating in these crosses was linked to Scnm1, dystonic F2 mice were genotyped for markers on chromosome 3. The data demonstrated linkage of the dystonic phenotype to Scnm1 in both crosses ( Fig. 7C and D) . The results indicate that strains DBA/2J and A/J also carry the dominant, resistant allele of Scnm1.
DISCUSSION
We have described a novel dystonic phenotype associated with profound deficiency of the voltage-gated sodium channel Scn8a. This is the first demonstration of dystonia resulting from mutation of an ion channel. The med J mouse differs from other animal models of dystonia in that the condition is persistent to adulthood and is not associated with neurodegeneration (27, 28) . The detection of a low level of full-length Scn8a transcripts in med J homozygotes demonstrates that the mutant splice donor site for exon 3, GTAACA, can be spliced at low efficiency. The med J mutation should therefore be classified as a hypomorphic allele. med J homozygotes carrying one or two copies of the modifier allele Scnm1 H survive to adulthood and are not paralyzed. Homozygotes for true null alleles of Scn8a cannot survive even in the presence of two copies of the Scnm1 H allele. Thus, prevention of paralysis and survival to adulthood requires both a low level of wild-type transcript and at least one copy of the dominant allele of Scnm1. C57BL/6J carries a recessive allele of Scnm1 that, in combination with a hypomorphic level of Scn8a, results in paralysis and lethality.
The lethal paralysis of med J mice is caused by failure of evoked neurotransmitter release at the neuromuscular junction (29, 30) . To rescue the lethal paralysis, it is likely that Scnm1 functions within the motor neuron or in muscle to increase sensitivity in response to reduced neuronal activity. Scn8a is known to be the major carrier of sodium current in spinal motor neurons during the neonatal period (31) . The severe muscle weakness in the dystonic mice is not surprising in view of the low level of correctly spliced Scn8a transcripts. The histological appearance of skeletal muscle suggests that some motor units fail while others remain functional in the dystonic animals.
Several molecular mechanisms of action for the modifier locus Scnm1 may be considered. It is unlikely that Scnm1 encodes a splicing factor that increases the efficiency of splicing of the mutant transcript, because the correctly spliced transcript accounted for only 2% of total Scn8a transcript in both paralyzed and dystonic mice. The modifier gene product could interact directly with Scn8a channels or could indirectly compensate for the low level of Scn8a by changing the excitability of neurons or skeletal muscle. If Scnm1 affects neuronal adaptation to low levels of Scn8a, it might also have a profound influence on the expression of other neuromuscular disorders. Having established the chromosomal location of Scnm1, it should be feasible to isolate this interesting gene by transgene complementation of the recessive lethal phenotype (32, 33) .
The dystonic phenotype of the med J homozygotes can be considered a direct consequence of the low level of Scn8a expression and suggests an important role of this channel in neurons involved in motor control. Two brain regions that have been implicated in motor control and human dystonia are the basal ganglia and cerebellum (34) (35) (36) (37) (38) . Cerebellar Purkinje cells isolated from Scn8a mutants are known to have reduced persistent sodium current and lack resurgent sodium current (39) . The ability of Purkinje cells from mutant mice to fire repetitive action potentials of the type produced by climbing fiber stimulation in vivo is severely compromised and may contribute directly to the dystonia. The electrophysiological characteristics of neurons in the basal ganglia of Scn8a mutant mice have not yet been investigated. The dystonic phenotype of med J mice suggests that the recently characterized human SCN8A gene (40) should be evaluated as a candidate gene for human inherited dystonias that are not linked to currently known loci.
Several examples of epistatic interaction between mammalian genes have recently been identified, including the digenic inheritance of retinitis pigmentosa due to mutations in peripherin/ RDS and ROM1 (41) , interaction between Pax2 and Pax5 during brain development (42) and the effect of secretory phospholipase (Mom) on tumor incidence in mice with Apc Min mutations (43) . The dramatic effect of Scnm1 on the survival of animals with the hypomorphic Scn8a allele demonstrates the power of the enhancer/suppressor screen approach for identifying loci affecting specific functional pathways in the mouse. The effect of strain background on the phenotype of med J mice also underscores the importance of using congenic lines for functional studies of new mutants (44) . We are developing congenic lines that carry the med J mutation on strain C57BL/6J (paralytic phenotype) and strain C3H (dystonic phenotype). Further analysis of the neurophysiology of dystonic med J mice will expand our understanding of the etiology of movement disorders.
MATERIALS AND METHODS
Animals
The med J allele of Scn8a arose at the Jackson Laboratory (Bar Harbor, ME) on a marker stock that carried a mutation at the Caracul locus (18) and was maintained on a (C57BL/6J × C3HeB/FeJ) F1 hybrid background. Heterozygous med J /+ mice can be identified by the wavy hair produced by the dominant Caracul mutation that is located <0.3 cM from Scn8a on distal chromosome 15. B6C3Fe-a/a, Ca med J /+ mice (N32) were obtained from the frozen embryo bank of the Jackson Laboratory in 1994 and have been maintained in our laboratory by crossing to strain C57BL/6J for eight generations. The inbred subline C3HeB/FeJ (C3H) was derived at the Jackson Laboratory in 1948 from strain C3H/HeJ by embryo transfer to strain C57BL/6J, which eliminated the mammary tumor virus carried by strain C3H/HeJ. The substrain C3HeB/FeJ-a/a, with black coat color, was generated at the Jackson Laboratory by crossing C3HeB/FeJ to C57BL/6J and backcrossing to C3HeB/FeJ.
The med tg mutation arose in 1991 as a result of non-targeted transgene insertion in a (C57BL/6J × C3H/HeJ) F2 mouse (26) and has been maintained in our colony by backcrossing to C57BL/6J for eight generations. Scn8a med arose on a mixed background that included strains C3H and 101 and has been maintained in our laboratory by backcrossing to C3H for three generations (17) . C57BL/6J mice were obtained from the Jackson Laboratory.
Brain and spinal cord histology
Dystonic mice between 5 and 9 months of age were examined (n = 7). Control sections from strains C57BL/6J (3 months old, n = 2) and C3H (9 months old, n = 2) were processed in parallel. Tissues were processed for cresyl violet, cytochrome oxidase or immunohistochemical staining as described (45) . The silver impregnation procedure to identify degenerating neurons was performed essentially as described (46) .
Skeletal muscle morphology
Gastrocnemius muscle and biceps brachii muscle from dystonic (n = 5) and C57BL/6J (n = 2) mice were dissected, fixed for 1-3 days in 10% formalin in phosphate-buffered saline and processed for routine hematoxylin/eosin staining. For histochemical stains, the same muscles were dissected and immediately frozen in isopentane cooled with dry ice. Cryostat sections (14 µm) were stained for succinate dehydrogenase or myofibrillar ATPase (pH 3.8, 4.3, 4.5, 9.4 and 10.4) as described (47) .
Transcript analysis
Total RNA was prepared from brain using the Trizol protocol (Life Technologies, Grand Island, NY). First strand cDNA was synthesized from 10 µg RNA with a random hexamer primer using the Superscript II RT Preamplification System (Life Technologies) in a 20 µl reaction according to the manufacturer's instructions. First strand cDNA (1 µl) was used as template in 25 µl PCR reactions. PCR was carried out for 20-25 cycles using the following primers as previously described (17): for exon 1, nested primers a and b; for exon 2, primer d; for exon 3, primer i; for exon 4, primer k; for exon 6, nested primers m and n.
For oligonucleotide hybridization experiments, PCR products were separated on 1.5% agarose and transferred by Southern blotting to nylon membranes (Zetaprobe; Bio-Rad, Hercules, CA). Membranes were baked for 30 min at 80_C under vacuum, prehybridized for 30-60 min, hybridized for 3 h at 45_C, washed twice for 20 min at 45_C in 2× SSC, 0.1% SDS and autoradiographed. Oligonucleotide probes (5 pmol) were end-labeled by T4 polynucleotide kinase (New England Biolabs, Beverly, MA) in the presence of 30 µCi of [α-32 P]ATP (6000 Ci/mmol; Amersham, Arlington Heights, IL). Oligo A (GTGGAGTACA-CATTCT) spans the junction between exons 3 and 4 in the wild-type transcript (Fig. 4A) . Oligo B (CGCAGAAAGTACA-CAT) spans the junction between exons 1 and 4 in the mutant transcript. The specificity of hybridization was confirmed by testing products of known sequence. The weak cross-hybridization of oligo A with the incorrectly spliced transcript was prevented by including a 5-fold excess of unlabeled oligo B in the hybridization solution. MultiAnalyst software (Bio-Rad) was used for densitometric analysis of autoradiogram images.
Microsatellite genotypes
Genomic DNA was prepared from tail biopsies by proteinase K digestion, phenol-chloroform extraction and ethanol precipitation. Primers for microsatellite loci were obtained from Research Genetics (Huntsville, AL). PCR products were detected by incorporation of [α-32 P]dCTP, electrophoresis on 6% polyacrylamide gels containing urea and autoradiography. (C57BL/6J × C3H) F1 parents of the F2 generation were confirmed to be heterozygous for markers on chromosome 3.
